首页|期刊导航|中国体外生命支持|静脉-动脉体外膜氧合与静脉-静脉体外膜氧合治疗重症患者死亡病例的回顾性分析

静脉-动脉体外膜氧合与静脉-静脉体外膜氧合治疗重症患者死亡病例的回顾性分析OA

Retrospective Analysis of Mortality in Critically Ill Patients Treated with V-A ECMO versus V-V ECMO

中文摘要英文摘要

目的 比较接受静脉-动脉体外膜氧合(V-A ECMO)与静脉-静脉体外膜氧合(V-V ECMO)支持并最终死亡患者的临床特征,为优化ECMO治疗策略、降低重症患者病死率提供临床参考.方法 回顾性分析中国科学技术大学附属第一医院收治的59例ECMO支持期间死亡患者的临床资料,根据支持模式分为V-A ECMO组(n=41)与V-V ECMO组(n=18).收集并比较两组患者的基线资料、并发症发生情况、支持时间及直接死亡原因.结果 两种支持类型的患者在年龄、性别及主要合并症方面未见明显差异.并发症发生率比较显示,所有患者出血最常见(总发生率52.54%),下肢缺血仅见于V-A ECMO组(19.51%).V-V ECMO组的住院时间及ECMO辅助时间均显著长于V-A ECMO组(P<0.05).在直接死亡原因方面,V-A ECMO组患者主要死于心源性休克(41.46%),而V-V ECMO组患者主要死于感染性休克(44.44%).结论 V-A ECMO与V-V ECMO治疗后死亡患者的基线临床特征无明显差异,但两组在ECMO治疗时长、主要直接死亡原因上存在较明显的差异,临床需根据患者病因特点优化ECMO支持策略,加强并发症防控,以改善重症患者预后.

Objective To compare the clinical characteristics of patients who died on veno-arterial extracorporeal membrane oxygenation(V-A ECMO)versus veno-venous extracorporeal membrane oxygenation(V-V ECMO)support,in order to provide clinical references for optimizing ECMO treatment strategies and reducing mortality in critically ill patients.Methods A retrospective analysis was performed on the clinical data of 59 patients who died during ECMO support at Anhui Provincial Hospital.According to the support mode,patients were divided into a V-A ECMO group(n=41)and a V-V ECMO group(n=18).Baseline data,incidence of complications,duration of ECMO support,and direct causes of death were collected and compared between the two groups.Results No significant differences were observed between the two groups regarding pa-tient age,gender,or major comorbidities.Analysis of complications revealed that bleeding complications were the most common overall(52.54%),while lower limb ischemia complications were observed only in the V-A ECMO group(19.51%).Both hospital length of stay and duration of ECMO support were significantly longer in the V-V ECMO group compared to those in the V-A ECMO group(P<0.05).Regarding direct causes of death,patients in the V-A ECMO group predominantly died of cardiogenic shock(41.46%),whereas patients in the V-V ECMO group mainly died of septic shock(44.44%).Conclusion Baseline clinical characteristics showed no significant differences between patients who died after VA-ECMO and VV-ECMO therapy.However,distinct differences existed between the two groups in terms of ECMO treatment duration and primary direct causes of death.It is necessary to optimize ECMO support strategies based on patient etiology and enhance the prevention and management of com-plications to improve the prognosis of critically ill patients.

程华应;黄宇昂;程光存;宣强;吴双正;黄方亮

皖南医学院研究生院,安徽 芜湖 241000中国科学技术大学附属第一医院心脏外科,合肥 230000中国科学技术大学附属第一医院心脏外科,合肥 230000中国科学技术大学附属第一医院泌尿外科,合肥 230000中国科学技术大学附属第一医院重症医学科,合肥 230000安徽中医药大学,合肥 230000

静脉-动脉体外膜氧合静脉-静脉体外膜氧合重症患者心源性休克院内死亡预后

veno-arterial extracorporeal membrane oxygenationveno-venous extracorporeal membrane oxygenationcritically ill patientscardiogenic shockin-hospital mortalityprognosis

《中国体外生命支持》 2026 (2)

139-143,151,6

安徽省2020年重点研究与开发计划(202004j07020018)安徽省2024年科学技术普及项目(KP202402012)

10.13498/j.cnki.chin.j.ecls.2026.02.10

评论